Christina Fuchs

Christina Fuchs possesses extensive experience in investment and consulting, currently serving as a Shareholder Representative and Board Observer at Kedrion Biopharma since September 2022, and as an Investment Professional at Permira since June 2022. Prior to these roles, Christina held various positions at Boston Consulting Group from August 2018 to March 2022, progressing from Associate to Project Leader. Additional experience includes an Investment Banking internship at Goldman Sachs in 2017 and consulting roles at Horváth & Partners and PwC. Christina Fuchs holds a Master of Arts in Business Innovation from the University of St.Gallen and a Bachelor of Science in Business Administration from the University of Mannheim, along with exchange semesters at CEIBS and Thammasat University.